Esperion Therapeutics Ownership | Who Owns Esperion Therapeutics?
Esperion Therapeutics Ownership Summary
Esperion Therapeutics is owned by 49.87% institutional investors, 0.56% insiders, and 49.57% retail investors. Blackrock is the largest institutional shareholder, holding 8.26% of ESPR shares. BB Biotech AG Ord is the top mutual fund, with 5.05% of its assets in Esperion Therapeutics shares.
ESPR Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Esperion Therapeutics | 49.87% | 0.56% | 49.57% |
| Sector | Healthcare Stocks | 488.17% | 11.08% | -399.26% |
| Industry | Specialty & Generic Drug Manufacturers Stocks | 43.51% | 11.55% | 44.95% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Blackrock | 13.98M | 8.26% | $31.04M |
| Blackrock funding, inc. /de | 14.71M | 7.47% | $14.48M |
| Vanguard group | 11.72M | 6.01% | $25.77M |
| Wasatch advisors lp | 10.34M | 5.25% | $10.18M |
| Two seas capital lp | 9.95M | 5.06% | $9.80M |
| Penderfund capital management | 6.68M | 3.39% | $6.57M |
| Marshall wace, llp | 5.31M | 2.70% | $5.21M |
| State street | 4.50M | 2.31% | $9.91M |
| Meditor group | 3.79M | 2.24% | $8.42M |
| Geode capital management | 4.34M | 2.23% | $9.55M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Meditor group | 3.79M | 15.57% | $8.42M |
| Indaba capital management | 3.00M | 2.18% | $2.95M |
| Penderfund capital management | 6.68M | 1.56% | $6.57M |
| Diametric capital, lp | 678.82K | 0.36% | $668.23K |
| Two seas capital lp | 9.95M | 0.16% | $9.80M |
| Summit wealth group | 157.00K | 0.10% | $345.00K |
| Wasatch advisors lp | 10.34M | 0.05% | $10.18M |
| Boomfish wealth group | 45.31K | 0.03% | $44.60K |
| Prelude capital management | 265.59K | 0.03% | $261.44K |
| Hap trading | 225.00K | 0.02% | $208.13K |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Blackrock | 13.98M | 0.00% | 11.14M |
| Penderfund capital management | 6.68M | 1.56% | 4.68M |
| Two seas capital lp | 9.95M | 0.16% | 3.02M |
| Morgan stanley | 3.33M | 0.00% | 1.69M |
| Marshall wace, llp | 5.31M | 0.01% | 1.68M |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Orbimed advisors | - | - | -13.71M |
| Bellevue group | - | - | -9.69M |
| Great point partners | - | - | -5.79M |
| Bank of america corp /de/ | 1.16M | 0.00% | -3.38M |
| Millennium management | 829.88K | 0.00% | -2.57M |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Umb bank, n.a. | 170.00K | 0.00% | 170.00K | $167.35K |
| Virtu financial | 132.23K | 0.02% | 132.23K | $291.00K |
| China universal asset management | 41.78K | 0.01% | 41.78K | $91.91K |
| J.w. cole advisors | 30.20K | 0.00% | 30.20K | $66.44K |
| Alpine global management | 17.73K | 0.00% | 17.73K | $17.45K |
Sold Out
| Holder | Change |
|---|---|
| Assetmark | -8.00 |
| True wealth design | -22.00 |
| Td waterhouse canada | -59.00 |
| Rothschild investment | -100.00 |
| Geowealth management | -102.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 30, 2025 | 168 | -11.58% | 98,172,969 | -13.34% | 49 | 1.49% | 67 | -17.28% | 44 | -21.43% |
| Mar 31, 2025 | 190 | -7.77% | 113,479,021 | -9.95% | 57 | 1.38% | 82 | -8.89% | 56 | 21.74% |
| Dec 31, 2024 | 86 | -56.78% | 36,541,743 | -71.74% | 18 | 0.43% | 38 | -51.28% | 15 | -65.91% |
| Sep 30, 2024 | 199 | 3.11% | 129,297,339 | -5.46% | 66 | 1.02% | 78 | -28.44% | 44 | 57.14% |
| Jun 30, 2024 | 193 | 14.20% | 136,759,025 | 9.15% | 80 | 0.65% | 109 | 12.37% | 28 | 7.69% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| BB Biotech AG Ord | 9.94M | 5.05% | - |
| Wasatch Ultra Growth | 7.02M | 3.54% | 345.40K |
| Pender Corporate Bond F | 6.36M | 3.18% | 359.98K |
| Vanguard US Total Market Shares ETF | 6.18M | 3.12% | - |
| Vanguard Total Stock Mkt Idx Inv | 6.05M | 3.02% | -133.35K |
| iShares Russell 2000 ETF | 4.74M | 2.37% | -90.09K |
| Wasatch Small Cap Growth Investor | 4.35M | 2.21% | -43.99K |
| Nuveen Quant Small Cap Equity R6 | 2.46M | 1.24% | -61.14K |
| Vanguard Institutional Extnd Mkt Idx Tr | 1.96M | 0.98% | -895.39K |
| Fidelity Small Cap Index | 1.92M | 0.97% | - |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Jul 17, 2025 | Looker Benjamin | General Counsel | Sell | $1.47K |
| Jul 17, 2025 | Halladay Benjamin | Chief Financial Officer | Sell | $12.27 |
| Jun 17, 2025 | Looker Benjamin | General Counsel | Sell | $7.40K |
| Jun 17, 2025 | Koenig Sheldon L. | President and CEO | Sell | $33.80K |
| Jun 17, 2025 | Halladay Benjamin | Chief Financial Officer | Sell | $8.33K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2025 Q3 | - | 2 |
| 2025 Q2 | - | 5 |
| 2025 Q1 | - | 7 |
| 2024 Q4 | - | 5 |
| 2024 Q3 | - | 5 |
ESPR Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools